Rhonda J Rosengren 25th Lorne Cancer Conference 2013

Abstracts this author is presenting:

• Combination therapy with raloxifene and a novel curcumin analog for the treatment of hormone refractory prostate cancer: in vitro mechanisms for synergistic cytotoxicity — Poster Session 2